Positive Results for Ebola Vaccine
August 27th 2014Immunovaccine Inc., a clinical stage vaccine company, announced on Aug. 25 positive results for a vaccine formulated in its DepoVax technology in an Ebola virus challenge study performed by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH.
China Closes In On US As Biggest Healthcare Market
August 26th 2014China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU).
mHealth Set to Transform Clinical Trials
August 19th 2014The health sciences industry received some important and encouraging news from the US Food and Drug Administration (FDA) in late June-an announcement that may, ultimately, help to transform the way data is collected in clinical trials and lead to safer studies and faster time to market.
Pharma Manufacturing Investments Reflect Key Industry Trends
August 14th 2014Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments. Pharmaceutical Technology’s Cynthia Challener offers summary of selected investments in both small- and large-molecule manufacturing facilities during the last year.
Emerging Pharma Leaders: Susanne Heinzinger
August 14th 2014To say that Susanne Heinzinger’s career trajectory has taken her from one spectrum of the healthcare arena to another may be an understatement. Before entering the pharmaceutical industry as a sales person, Heinzinger, who earned a Bachelor of Business Administration degree in accounting, worked as an auditor; she picked the job of auditing hospitals and home healthcare companies, mainly because she had always had an interest in the healthcare industry.
New Products Will Force 'Radical Shift' in Hemophilia Drug Market
August 13th 2014The hemophilia treatment landscape is to undergo a radical shift away from established short-acting therapies, beginning with the launch of Biogen Idec’s long-acting rFVIII and rFIX products this year, according to research and consulting firm GlobalData.
More Than Half of US Approved Drugs Developed by Collaborating Companies
August 12th 2014According to the Tufts Center for the Study of Drug Development R&D Management Report, more than half of all new drugs approved in the US between 2000 and 2011 were developed by companies that collaborated in one form or another with other entities.
Brown University’s Executive Masters in Healthcare Leadership: A Mission to Transform
August 11th 2014Mid-career students at Brown University’s new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos that slow innovations in the delivery and financing of healthcare.
Pharma & Biotech Most Active Sector in UK M&As
August 11th 2014The pharma, medical and biotech (PMB) sector, driven by the Novartis’s £8.6bn acquisition of GlaxoSmithKline’s oncology division, was the most active industry in UK M&A in H1 2014, with a 26.9% market share (£10.1bn), according to Mergermarket’s latest deal round-up.